Pharmaceuticals

Emphysema Treatment Industry Overview 2025: Growth Projections and Market Trends

November 8, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Future Market Size Estimation For The Emphysema Treatment Market Covering 2025–2034?

The emphysema treatment market has demonstrated consistent expansion in recent years. Projections indicate it will expand from $5.15 billion in 2024 to $5.4 billion by 2025, exhibiting a compound annual growth rate (CAGR) of 5.0%. Historically, this growth has been driven by factors such as the profound impact of the smoking epidemic, significant advancements in medications, the proliferation of pulmonary rehabilitation programs, the development of enhanced diagnostic tools, and increased awareness and education initiatives.

The emphysema treatment market size is anticipated to experience robust expansion in the coming years. It is projected to grow to $7.28 billion in 2029, exhibiting a compound annual growth rate (CAGR) of 7.7%. This expansion during the forecast period can be attributed to factors such as an aging population, personalized treatment approaches, broader access to therapies, a greater emphasis on symptom management, and collaborative healthcare models. Significant trends anticipated in this period include the exploration of gene therapies, increased patient education and empowerment, the integration of artificial intelligence (AI), enhanced accessibility to treatment, and advancements in long-acting medications.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10807&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Emphysema Treatment Industry?

The growing incidence of chronic obstructive pulmonary disease (COPD) is projected to stimulate the expansion of the emphysema treatment market in the future. COPD refers to a group of conditions, including emphysema and chronic bronchitis, that obstruct airflow and cause breathing difficulties. Emphysema therapies are crucial in mitigating the progression of COPD, as their focus is on alleviating symptoms, restoring lung function, and delaying the disease’s advancement. For instance, in June 2024, reports from the Australian Institute of Health and Welfare (AIHW), an Australia-based agency, estimated that in 2022, about 638,000 people, or 2.5% of the population in Australia, were affected by COPD. By 2023, COPD’s contribution to the overall disease burden had climbed to 3.6%, constituting 50% of the total burden associated with respiratory conditions. Furthermore, in 2022, COPD was the direct cause of 7,691 deaths, which equals 29.6 deaths per 100,000 people and represented 4.0% of all fatalities in the country. Thus, the escalating prevalence of chronic obstructive pulmonary disease (COPD) cases is a significant driver for the emphysema treatment market.

What Are The Major Segments Identified In The Emphysema Treatment Market?

The emphysema treatment market covered in this report is segmented –

1) By Treatment: Smoking Cessation, Bronchodilators, Steroids, Leukotriene Modifiers, Supplemental Oxygen, Antibiotics, Gene Therapy, Surgery Transplant, Other Treatments

2) By Distribution Channel: Online Providers, Drug Stores and Retail Pharmacies, Hospital Pharmacies

3) By End-User: Clinics, Surgical Centre, Other End-Users

Subsegments:

1) By Smoking Cessation: Nicotine Replacement Therapy (NRT), Prescription Medications, Behavioral Therapy Programs

2) By Bronchodilators: Short-Acting Beta-Agonists (SABAs), Long-Acting Beta-Agonists (LABAs), Anticholinergics

3) By Steroids: Inhaled Corticosteroids (ICS), Oral Corticosteroids, Combination Inhalers

4) By Leukotriene Modifiers: Montelukast, Zafirlukast

5) By Supplemental Oxygen: Portable Oxygen Concentrators, Continuous Flow Oxygen Systems, Pulse Dose Oxygen Systems

6) By Antibiotics: Macrolides, Fluoroquinolones, Tetracyclines

7) By Gene Therapy: Gene Replacement Therapy, Antisense Oligonucleotides

8) By Surgery Transplant: Lung Volume Reduction Surgery (LVRS), Lung Transplantation

9) By Other Treatments: Pulmonary Rehabilitation Programs, Nutritional Support, Palliative Care

What Trends Are Redefining The Emphysema Treatment Market Dynamics?

Leading firms within the emphysema sector are creating less invasive methods for patients to secure a market advantage. These procedures denote medical or surgical approaches executed with minimal disturbance to the body’s natural anatomy. An illustration of this is the introduction of Zephyr Valve surgery by Adena Health System, a US healthcare provider, in January 2022. This minimally invasive operation presents an option beyond standard lung volume reduction surgery for individuals suffering from lung hyperinflation, frequently observed in emphysema and COPD. The pioneering technique entails inserting small, unidirectional Zephyr Valves into the lung airways using a bronchoscope. These valves enable the expulsion of trapped air, hinder further buildup, permit expansion of healthier lung regions, and consequently enhance respiration.

Which Leading Companies Dominate The Emphysema Treatment Market Share?

Major companies operating in the emphysema treatment market include AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Novartis AG, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Boehringer Ingelheim GmbH, Mylan N.V., Pfizer Inc., Orion Oyj, Verona Pharma PLC, Pulmonx Corporation, Emphasys Medical Inc., Halozyme Therapeutics Inc., Mariposa Health Limited, Uptake Technologies Inc., Respinova Ltd, Gala Therapeutics Inc., Pulmatrix Inc., Broncus Medical Inc., Holaira Inc., PneumRx Inc., Spiration Inc., Aeris Therapeutics Inc., CSA Medical Inc., Olympus Corporation

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/emphysema-treatment-global-market-report

What Regional Growth Trends Are Shaping The Emphysema Treatment Market Outlook?

North America was the largest region in the emphysema treatment market in 2024. The regions covered in the emphysema treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Emphysema Treatment Market Report:

https://www.thebusinessresearchcompany.com/customise?id=10807&type=smp

Browse Through More Reports Similar to the Global Emphysema Treatment Market 2025, By The Business Research Company

Inflammatory Bowel Disease Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

Point Of Entry Water Treatment Systems Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/point-of-entry-water-treatment-systems-global-market-report

Point Of Use Water Treatment Systems Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/point-of-use-water-treatment-systems-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795